Since the SARS-CoV-2 virus uses this receptor as entry pathway in host cells, higher degradation of ACE2 could lead to a long-lasting inflammatory cytokine storm, oxidative stress, and hemostasis activation, which are all hallmarks of severe/critical COVID-19 illness [69]. The gene discussed is ACE2; the disease is COVID-19.